The use of short-term tests to measure the preventive action of reducing agents on formation and activation of carcinogenic nitroso compounds.
The effect of reducing agents on the nitrosation of methylguanidine (MG) and on the in vitro activation of dimethylnitrosamine (DMN) was examined by measuring DNA-repair synthesis (unscheduled incorporation of [3h]TdR), shifts in alkaline sucrose gradients, frequency of chromosome aberrations, and clone-forming capacity of cultured human fibroblasts. The reducing agents examined were sodium ascorbate, cysteine, cysteamine, and propyl gallate. Since the short-term bioassays used can be quantitated, it has become relatively easy to detect the inhibitory action of reducing compounds on the nitrosation reaction of MG and metabolic activation (with S-9 preparation) of the precarcinogen DMN, to measure their effective dose range, and to establish the most effective ratios between inhibitory agent and reactant. The results indicate that DNA-repair synthesis is a suitable short-term test for studying the numerous combinations and premutations between several carcinogenic or non-carcinogenic agents, and for estimating the capacity of inhibitory agents to affect formation and activation of chemical carcinogens.
D000293:Adolescent; D000328:Adult; D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology*; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D003543:Cysteamine / Q000494:pharmacology*; D003545:Cysteine / Q000494:pharmacology*; D004260:DNA Repair; D004128:Dimethylnitrosamine / Q000037:antagonists & inhibitors; D004347:Drug Interactions; D005707:Gallic Acid / Q000031:analogs & derivatives*; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D009603:Nitroso Compounds / Q000037:antagonists & inhibitors*; D011435:Propyl Gallate / Q000494:pharmacology*
D009603:Nitroso Compounds; D003543:Cysteamine; D005707:Gallic Acid; D011435:Propyl Gallate; D003545:Cysteine; D004128:Dimethylnitrosamine; D001205:Ascorbic Acid